https://www.selleckchem.com/pr....oducts/onx-0914-pr-9
cal significance of the interaction is currently unclear. Concurrent EI-ASM and DOAC use presents a possible risk for DOAC concentrations below the expected range. The clinical significance of the interaction is currently unclear. Our objective was to update the understanding of the development of paradoxical immune-mediated glomerular disorders (IGDs) in patients with rheumatic diseases treated with biologics and targeted synthetic drugs (ts-drugs). A systematic literature review was performed by searching PubMed for articles p
Like
Comment
Share
